Selected article for: "cc NC International license and high risk"
Author: Zhichao Feng; Qizhi Yu; Shanhu Yao; Lei Luo; Junhong Duan; Zhimin Yan; Min Yang; Hongpei Tan; Mengtian Ma; Ting Li; Dali Yi; Ze Mi; Huafei Zhao; Yi Jiang; Zhenhu He; Huiling Li; Wei Nie; Yin Liu; Jing Zhao; Muqing Luo; Xuanhui Liu; Pengfei Rong; Wei Wang
Title: Early Prediction of Disease Progression in 2019 Novel Coronavirus Pneumonia Patients Outside Wuhan with CT and Clinical Characteristics
  • Document date: 2020_2_23
    • ID: j0ufth5d_24
    Snippet: With the increase of newly confirmed and severe cases, the management of severe patients brings huge challenge in efficiently controlling the COVID-19 outbreak. Some patients progressed rapidly with ARDS and subsequent multiple organ dysfunction syndrome (MODS). 2 Early identification of patients with high risk to develop ARDS or MODS and risk stratification management might be helpful to reduce mortality. In our cohort, the prevalence of severe .....
    Document: With the increase of newly confirmed and severe cases, the management of severe patients brings huge challenge in efficiently controlling the COVID-19 outbreak. Some patients progressed rapidly with ARDS and subsequent multiple organ dysfunction syndrome (MODS). 2 Early identification of patients with high risk to develop ARDS or MODS and risk stratification management might be helpful to reduce mortality. In our cohort, the prevalence of severe NCP was 10.6%, which was . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • cc NC ND International license and high risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc NC ND International license and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc NC ND International license and mortality reduce: 1, 2, 3, 4
    • cc NC ND International license and outbreak control: 1, 2, 3, 4, 5, 6, 7
    • cc NC ND International license and risk stratification: 1
    • dysfunction syndrome and early identification: 1, 2
    • dysfunction syndrome and high risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • dysfunction syndrome and International license: 1
    • dysfunction syndrome and MODS organ dysfunction syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • dysfunction syndrome and mortality reduce: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • dysfunction syndrome and multiple MODS organ dysfunction syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • dysfunction syndrome and organ dysfunction syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • dysfunction syndrome and rapidly progress: 1, 2, 3, 4, 5, 6, 7, 8
    • dysfunction syndrome and risk stratification: 1, 2, 3
    • early identification and multiple MODS organ dysfunction syndrome: 1, 2
    • early identification and organ dysfunction syndrome: 1, 2
    • early identification and outbreak control: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • early identification and rapidly progress: 1, 2, 3, 4
    • early identification and risk stratification: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25